Sale!

Influenza Vaccines

$50.00 $40.00

They are attached and very specific. Please read the entire attachment carefully and completely. Two parts will be due separately but on the same day.

Part 1 Outline Phase (Wednesday December 2nd): Your working group will prepare an outline of the proposed project. The outline should be based on the readings and discussions among all of your group members. Your group will submit a single outline as a collaborative document within the Group discussion area.

The outline should include a working thesis statement, a preliminary title, and the main and subtopics you plan to cover. Acceptable formats include a bulleted or standard letter/number outline. The working thesis statement should be written as a single complete sentence, topic and subtopics may be written as complete sentences or phrases (see topic Thesis in the Project 1 Instructions for links to examples).

Part 2 Report Phase (Wednesday, December 3rd): Your working group will prepare a final collaborative report. The report will incorporate the information and your ideas into a single cohesive document that reads well, has a good overall flow of information, and includes in-text citations. Your group will submit a single document within the Study Group. Wikipedia and Blogs are not acceptable as primary sources of information.

The report will also include:

– a reference list formatted in APA style (be consistent throughout the document)

– a glossary defining the medical and scientific terms that may not be familiar to a student taking this course

– a final page where each working group member has written 1 to 3 sentences describing his or her role and contributions to the project. This is required to earn points for Project 2.

As noted above, your working group’s collaborative project may be submitted as a formal report, a testimonial to congress to request funds, a grant application, a brochure, or other format approved by the instructor. However, your project must focus on 2009-H1N1, seasonal influenza, and potential future influenza pandemics in either the U.S. or developing countries and include the other required components listed above.

The purpose of your project is to clearly explain your topic in your own words (define scientific terms used) the topic to help your audience understand the concepts and issues.

Category:

Description

Influenza Vaccines

According to the CDC, influenza is a contagious respiratory illness caused by the influenza virus. The illnesses range from mild to severe. In some cases, it results in the death of the victims or hospitalizations in acute care units. The risk of getting influenza infection differs based on age. Older people and children are at a high risk of getting infected because of their fragile immune systems. Currently, the best protection against influenza is vaccination (Grohskopf, et al., 2013). The effect if infection on individuals also differs. Some people might show mild flu symptoms and recover within weeks. However, some individuals might get hospitalized and be put under acute care. Symptoms include coughs, sore throat, chills, runny nose, body aches, headaches, fatigues, and in some cases vomiting and diarrhea (FDA, 2014). For adverse infections, patients often develop complications. The complications include pneumonia, bronchitis, sinus and ear infections. It also worsens chronic health problems such as heart disease, asthma, liver disorders, and metabolic disorders among others. People that are at risk of getting infected include older individuals aged 64 and above, children below the age of five, and pregnant women and people that live in nursing homes (FDA, 2014).

The unpredictable nature of flu makes it hard to control. The severity of the illness varies from season to season. Nonetheless, scientists base extent of severity on factors such as the availability of vaccines, the nature of the virus, the number of individuals vaccinated, and the match of the vaccine to the flu virus. Statistics shows that between 1976 and 2006, the U.S recorded deaths between a low of 3,000 to a high of 49,000 from influenza complications (Grohskopf, et al., 2013). Additionally, 80 to 90 percent of flu-related deaths occurred in older people aged 65 years and older (PCAST, 2009). This shows that scientists need to develop vaccines that will help older individuals reduce the risk of developing flu-related complications……………..

 

Related products